Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
6/18/2019
NHSA: Centralized Tender Purchase of Drugs to be Expanded Further in 2...
6/18/2019
Snapshot of BMI System Financial Performance in 01-04/2018
6/18/2019
NMPA Issues Guidelines for Clinical Safety Literature Appraisal of Mar...
6/18/2019
NHC: Public Hospitals Receive Increasing Financial Support from the Go...
6/18/2019
Bribes and Backdoor Deals Help Foreign Firms Sell to China's Hospitals
6/17/2019
WSJ: China Biotechs Lure Industry Talents in the U.S.
6/17/2019
CASI Pharmaceuticals Acquires Worldwide Rights To Commercialize anti-C...
6/17/2019
Deciphera Pharma and Zai Lab Announce Exclusive License Deal for Ripre...
6/17/2019
No. of Retail Pharmacies Hits Historical High as Retail Drug Sales Gro...
6/17/2019
NHC Expects to Reduce Drug Price Further As 4+7 Trial Advances
6/14/2019
Theravance and Mylan Expand YUPELRI (revefenacin) Deal to include Grea...
6/14/2019
Sinovant Granted Chinese Clinical Trial Approval for Lefamulin
6/14/2019
Solvotrin and Fosun Agree to China Deal for Iron Deficiency Drug
6/14/2019
Chi-Med Announces Successful Surufatinib Phase III Study in China
6/14/2019
BeiGene Announces Preliminary Phase 2 Results of Tislelizumab for Naso...
6/14/2019
Beigene Touts 'Encouraging' Response Rates as It Mounts Challenge To B...
6/14/2019
NMPA Restores Import of Fabrik Evers' HITRECHOL
6/13/2019
AstraZeneca Markets an Herbal-Based Remedy to Expand in China
6/13/2019
111 Enters Strategic Partnership Deal with Tong Ren Tang Tech to Advan...
6/13/2019
SEC probes Siemens, GE, Philips in alleged China medical equipment sch...
6/13/2019
Athenex and PharmaEssentia Announce Positive Early Clinical Signals of...
6/13/2019
Chinese Biopharma Firm Epimab Bags $74m Series B
6/13/2019
Parexel Teams with CLARINESS to Enhance Patient Access and Engagement ...
6/13/2019
BeiGene CEO John Oyler Elected to BIO Board of Directors
6/13/2019
US Senators Questions HHS Money and Chinese Genomics Firms
6/13/2019
China Launches Nasdaq-style Tech Board in Shanghai, Expects challenges
6/13/2019
China Approves First Human Trials of 4-Way Norovirus Vaccine
6/13/2019
Guangdong Highsun's Swine Fever Vaccine Met with Skepticism
6/13/2019
R2 Dermatology Signs Exclusive Asia-Pacific Distribution Agreement wit...
6/13/2019
Athenex Voluntarily Suspends Production at Its Chongqing API Plant
Page:
304
/
801
Total number of articles:
24028
:
[First]
[<<]
[302]
[303]
[304]
[305]
[306]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit